Biotech Startups

BioCircuit Technologies develops advanced medical devices for tissue repair and neuromodulation, with specialization in biomaterials, nitinol design, and bioelectronics. The company serves surgical teams with products like Nerve Tape®, a sutureless device for nerve repair.

1 investor

BioClé is a biotechnology company developing a delivery platform based on bacterial extracellular vesicles (bEVs) to improve the stability, bioavailability, and cellular uptake of bioactive compounds.

1 investor

Biocomposites develops and manufactures calcium-based and medical-grade polymer composite devices used in orthopaedic surgery, including products designed for use in the presence of infection. Founded via a management buyout of a ceramics company, it manufactures around one million units annually and sells to 100 countries.

1 investor

BioCompute is developing DNA-based data storage technology, offering exclusive pilot programs for early access. The company operates in the data storage and biotechnology space.

1 investor

1 investor

BioConnection is a Contract Development and Manufacturing Organization (CDMO) specializing in filling, finishing, and lyophilizing injectable biopharmaceutical products. The company operates from EMA and US-FDA-approved facilities in Oss, the Netherlands, serving innovative and generic pharmaceutical companies throughout the drug development lifecycle.

1 investor

BioCorteX builds a biology-based knowledge graph of microbiome samples (Carbon Knowledge) and a foundational emulator (Carbon Mirror) that models interactions between bacteria, the human immune system, diseases, and drugs to generate insights for drug discovery and development. Its products serve the pharmaceutical and therapeutics industry.

1 investor

BioCraft Pet Nutrition develops cell-cultured nutrition for cats and dogs, producing key nutrients for carnivorous pets without relying on conventionally farmed animals. The company focuses on pet food that reduces the environmental impact of animal-based ingredients.

1 investor

Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.

1 investor

BioDefense makes portable sensors that detect pathogens at the point of sampling in food and water. The devices test for several targets at once and return results in roughly 15 minutes, which shortens the wait associated with sending samples to a laboratory. Customers are industrial food and water operations managing contamination risk.

1 investor

Develops edible, natural coatings and feed additives to extend the shelf life of perishable foods such as fish, seafood, meat, fruits and vegetables, and to improve poultry and aquaculture farm productivity. Products serve food suppliers and farms across the food supply chain, with additional packaging and cold-chain logistics solutions.

1 investor

Bio Design Lab develops biopharmaceuticals using synthetic biology and systems-level genetic and genomic design. Its initial focus is advancing retroviral and lentiviral vector platforms that serve as foundational technologies for cell and gene therapies.

1 investor

Biodimension develops tissue engineering and non-animal testing methods including in-vitro platforms, biofabricated tissues, and computational models for pharmaceutical, personal care, and agrochemical industries. The company provides alternatives to animal testing for preclinical research and regenerative medicine applications.

1 investor

Biodiversity Intelligence measures and monitors biodiversity by combining eDNA sampling of soil and water, satellite and SAR remote sensing, climate data, and deep learning to produce standardized nature indices and indicators. It targets nature-market and land-use project operators, supporting nature disclosure, certification, and nature-based solutions through an interactive monitoring dashboard.

1 investor

BioDlink is a contract development and manufacturing organization (CDMO) providing drug development and manufacturing services for biopharmaceutical companies, with specialization in antibody-drug conjugates (ADCs).

1 investor

Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.

1 investor

Bioefekts is a Latvian agricultural biotech company that develops microbial-based soil amendments and plant growth products for greenhouse and field cultivation, including nitrogen-fixing bacteria, phosphorus-solubilizing microbes, and antifungal agents.

1 investor

Bioelectrix develops a novel electrical stimulation technology to accelerate wound healing by delivering stable, controlled electrical signals to tissue. The company targets diabetic foot ulcers and other chronic wounds, with initial focus on patients for whom small wounds can become life-threatening complications.

1 investor

Bioelectronica develops hardware and software tools for accelerated antibody discovery using single-cell protein secretion sorting combined with AI-driven sequence analysis. The company serves research institutions and biotech firms in the life sciences industry.

1 investor

Bioemtech provides in vitro cell-based assays and laboratory services for drug discovery and stem cell therapy applications, utilizing cell lines and standardized protocols to measure cytotoxicity, biological activity, and biochemical mechanisms for pharmaceutical research.

1 investor

BioGaia develops and markets probiotic supplements for consumer health, with a particular focus on infant nutrition. The company manufactures most products in-house in Sweden and distributes globally to healthcare professionals and consumers.

1 investor

Biogaran is a French pharmaceutical brand focused on generic medicines and health products, offering health-related content and patient support initiatives. It serves patients and caregivers in France with wellness information and community programs.

1 investor

Biogazelle develops RNA biomarker discovery and transcriptome profiling solutions for clinical research and diagnostics. The company specializes in innovative RNA analysis technologies for medical applications.

1 investor

Biogea develops agrotechnology products based on beneficial fungi and bacteria to increase crop yields for agricultural producers in a sustainable way. The company serves farmers with biological inputs marketed under brands including BIOGROW3 and Nitro Aire.

1 investor